This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, S. S.
Right arrow Articles by Khoury, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, S. S.
Right arrow Articles by Khoury, M. J.
Related Collections
Right arrow Respiratory Tract

PEDIATRICS Vol. 107 No. 2 February 2001, pp. 274-279

Early Diagnosis of Cystic Fibrosis in the Newborn Period and Risk of Pseudomonas aeruginosa Acquisition in the First 10 Years of Life: A Registry-Based Longitudinal Study

Received Jan 7, 2000; accepted May 22, 2000.

Sophia S. Wang*, Dagger , Stacey C. FitzSimmons§, Leslie A. O'LearyDagger , Michael J. Rockparallel , Marta L. GwinnDagger , and Muin J. KhouryDagger

From the * Epidemic Intelligence Service, Division of Applied Public Health Training, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, Georgia, and Dagger  Office of Genetics and Disease Prevention, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia, and § Cystic Fibrosis Foundation, Bethesda, Maryland and parallel  University of Wisconsin Hospital and Clinics, Madison, Wisconsin.

Objective.  Controlled clinical trial data have suggested that identifying asymptomatic cystic fibrosis (CF) patients through newborn screening improves health outcomes of affected children in the first decade of life. However, it is unclear whether these improvements also include a reduction in risk for bronchial infection, the major determinant of CF morbidity. The authors therefore investigated the association between early CF diagnosis and acquisition of Pseudomonas aeruginosa, the major bronchial pathogen, in the first decade of life.

Methodology.  Longitudinal data on 3625 CF patients diagnosed between 1982 and 1990 and before 36 months of age were ascertained from the National Cystic Fibrosis Patient Registry. We compared P aeruginosa acquisition in the first 10 years of life among 4 groups: EAD (early asymptomatic diagnosis)---<6 weeks, by pre/neonatal screening, genotype, family history (n = 157); ESD (early symptomatic diagnosis) (n = 227); LAD (late asymptomatic diagnosis)---6 weeks to 36 months (n = 161); and LSD (late symptomatic diagnosis) (n = 3080). P aeruginosa acquisition was determined from yearly sputum and/or bronchoscopy cultures. Children whose CF diagnoses followed meconium ileus or whose cultures were obtained only from nasal samples were excluded from the study.

Results.  Kaplan Meier analyses for P aeruginosa acquisition were conducted for each diagnostic group. Regression models were used to generate adjusted relative hazards with EAD as the referent group. Relative hazards were 0.9 (95% confidence interval [CI]: 0.7-1.2) for ESD, 0.8 (95% CI: 0.6-1.2) for LAD, and 1.0 (95% CI: 0.7-1.2) for LSD. The risk of acquiring P aeruginosa was therefore not significantly different between children diagnosed early, late, asymptomatically, or symptomatically.

Conclusions.  These data suggest that, despite improvements in other health outcomes from newborn screening for CF, early asymptomatic diagnosis of CF does not affect P aeruginosa acquisition.  Key words:  cystic fibrosis, Pseudomonas aeruginosa, neonatal screening, Kaplan Meier, epidemiology.




This article has been cited by other articles:


Home page
 PediatricsHome page
I. Baussano, I. Tardivo, R. Bellezza-Fontana, M. P. Forneris, A. Lezo, L. Anfossi, M. Castello, V. Aleksandar, and E. Bignamini
Neonatal Screening for Cystic Fibrosis Does Not Affect Time to First Infection With Pseudomonas aeruginosa
Pediatrics, September 1, 2006; 118(3): 888 - 895.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. M. Farrell, Z. Li, M. R. Kosorok, A. Laxova, C. G. Green, J. Collins, H.-C. Lai, M. J. Rock, and M. L. Splaingard
Bronchopulmonary Disease in Children with Cystic Fibrosis after Early or Delayed Diagnosis
Am. J. Respir. Crit. Care Med., November 1, 2003; 168(9): 1100 - 1108.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
M. E. Merelle, J. Huisman, A. Alderden-van der Vecht, F. Taat, D. Bezemer, R. W. Griffioen, G. Brinkhorst, and J. E. Dankert-Roelse
Early Versus Late Diagnosis: Psychological Impact on Parents of Children With Cystic Fibrosis
Pediatrics, February 1, 2003; 111(2): 346 - 350.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
B. M. Assael, C. Castellani, M. B. Ocampo, P. Iansa, A. Callegaro, and M. G. Valsecchi
Epidemiology and Survival Analysis of Cystic Fibrosis in an Area of Intense Neonatal Screening Over 30 Years
Am. J. Epidemiol., September 1, 2002; 156(5): 397 - 401.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
S. E. H. West, L. Zeng, B. L. Lee, M. R. Kosorok, A. Laxova, M. J. Rock, M. J. Splaingard, and P. M. Farrell
Respiratory Infections With Pseudomonas aeruginosa in Children With Cystic Fibrosis: Early Detection by Serology and Assessment of Risk Factors
JAMA, June 12, 2002; 287(22): 2958 - 2967.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
S. D. Grosse, M. J. Khoury, W. H. Hannon, C. A. Boyle;, and P. M. Farrell
Early Diagnosis of Cystic Fibrosis
Pediatrics, June 1, 2001; 107(6): 1492 - 1492.
[Full Text] [PDF]